Trials / Completed
CompletedNCT06020807
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 168 (actual)
- Sponsor
- Nucleix Ltd. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
This is a prospective study to establish the analytical specificity of Bladder EpiCheck test in urine samples from healthy population and urology patients without prior history or evidence of bladder cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Bladder EpiCheck | Bladder EpiCheckTM (EpiCheck) is a urine test for monitoring of recurrence of NMIBC based on analysis of 15 informative DNA methylation biomarkers. |
Timeline
- Start date
- 2019-09-05
- Primary completion
- 2020-01-08
- Completion
- 2020-01-08
- First posted
- 2023-09-01
- Last updated
- 2023-09-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06020807. Inclusion in this directory is not an endorsement.